TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical trial NCT03123393 · TERMINATED
Trial details
- NCT number
- NCT03123393
- Sponsor
- Calithera Biosciences, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2019-12-17
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.